The National Institutes of Health (NIH) along with their National Institutes of Child Health and Human Development (NICHD) and the […]
Gilead’s inhaled version of remdesivir (Veklury) could add considerable value to the COVID-19 market. Potentially, the drug could be used […]
The World Health Organization (WHO) has shared interim results from the international, open-label trial published recently in the New England […]
With the COVID-19 pandemic conditions improving in India according to some local reports, the demand for antiviral drugs Remdesivir and […]
Much attention was placed on the antiviral drug remdesivir during the early stages of the COVID-19 pandemic. In fact, considerable public […]
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institute of Health (NIH), recently produced results […]
This week, Eli Lilly and Company and Incyte announced the publication of the New England Journal of Medicine’s peer-reviewed results […]
The World Health Organization (WHO) advises against using Remdesivir under any circumstances. Apparently, a prominent group of intensive care doctors […]
In the early stages of the COVID-19 pandemic, those involved in monitoring new drugs that may help inhibit the SARS-CoV-2 […]
Keith Speights writes for investment advisory website Motley Fool and brings the eclectic and varied background TrialSite appreciates. Mr. Speight highlighted […]
